An update on pharmacotherapies in active development for the management of cancer regimen-associated oral mucositis
Abstract Introduction: Oral mucositis (OM) is a common toxicity of cytotoxic cancer regimens and remains one of the most painful, injurious, and treatment-disrupting side effects of radiation and ablative therapy. Despite its frequency and impact, approved definitive preventive or therapeutic options remain limited. Areas covered: This review focuses on mechanistically active small molecules and biologicals…